PHYSICIANS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Objectives (ACCME, ANCC, ACPE)
- Review new emerging Hematology therapies for Multiple Myeloma, Waldenström’s Macroglobulin, Lymphoplasmacytic Lymphoma, Polycythemia Vera and Myelofibrosis.
- Determine which targeted therapies will be appropriate for patients diagnosed with Indolent & Mantel Cell, Hodgkin’s Lymphoma and Myelodysplastic syndrome.
- Evaluate which biological therapies (beyond CHOPing) that are effective in treating patients with Acute Lymphoblastic Leukemia and other Lymphomas.
- Discuss current treatment options for patients with Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
- Implement best practices for the identification and treatment of patients who are candidates for Hematopoietic Stem Cell transplantation.
- Review updated best practices for identifying, diagnosing and treating patients with Chronic Myeloid Leukemia, Essential Thrombosis, Eosinophilia Mastocytosis
- Discuss challenging hematologic malignancy cases and assess potential solutions for optimal patient care.
Physician Accreditation Statement
This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Indy Hematology Education, Inc. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Purdue University College of Pharmacy designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)™. Symposium – 8:00 am – 6:45 pm. Purdue University College of Pharmacy designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™ (Town Hall Interactive Meeting – 7 – 8:30 pm). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any commercial financial affiliations with ineligible companies. Full disclosure of all relationships must be made in writing to the audience prior to the activity with mitigation results.
NURSES
In order to receive CE, you must attend the entire Symposium from 8:00 am – 6:45 pm. Successful completion of this CME activity requires participants to complete a Post-Evaluation.
Nurses Accreditation Statement
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This program is approved for 8.75 contact hours (Symposium: 8:00 am – 6:45 pm).
This program is approved for 1.5 contact hours (Town Hall Interactive Meeting: 7:00 pm – 8:30 pm).
PHARMACISTS
In order to receive CE, you must attend the entire Symposium from 8:00 am – 6:45 pm. Successful completion of this CME activity requires participants to complete a Post-Evaluation.
Pharmacists Accreditation Statement
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/ equal opportunity institution.
Symposium: 8:00 am – 6:45 pm.
Universal Activity Number (UAN): 0018-9999-22-013-L01-P
This program is approved for 8.75 contact hours (0.875 CEU’s).
Town Hall Interactive Meeting: 7 – 8:30 pm.
Universal Activity Number (UAN): 0018-9999-22-014-L01-P
This program is approved for 1.5 contact hours (0.15 CEU’s).